Evidence map›Paper›PMID 41755632›Full record

ArticleNucleic acids research2026

Multisite phosphorylation of the AML-linked C-terminal of nucleophosmin (NPM1) orchestrates protein stability, DNA binding and charge block-driven phase separation.

Pablo Rivero-García, Rafael L Giner-Arroyo, Joaquín Tamargo-Azpilicueta, Abbey Telfer, Elisa Frezza, Adrián Velázquez-Campoy, Sofía Díaz-Moreno, Miguel A De la Rosa, Irene Díaz-Moreno

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pablo Rivero-GarcíaInstitute for Chemical Research-cicCartuja, University of Seville-CSIC, 41092 Seville, Spain.ORCID 0009-0002-2454-4056
Rafael L Giner-ArroyoInstitute for Chemical Research-cicCartuja, University of Seville-CSIC, 41092 Seville, Spain.ORCID 0000-0003-2651-7916
Joaquín Tamargo-AzpilicuetaInstitute for Chemical Research-cicCartuja, University of Seville-CSIC, 41092 Seville, Spain.ORCID 0000-0001-8504-4472
Abbey TelferDiamond Light Source-Harwell Science & Innovation Campus, OX11 0DE Didcot, United Kingdom.ORCID 0000-0002-7525-8052
Elisa FrezzaUniversité Paris Cité, CiTCoM, CNRS, F-75006 Paris, France.ORCID 0000-0003-0122-7859
Adrián Velázquez-CampoyInstitute for Biocomputation and Physics of Complex Systems (BIFI), and Department of Biochemistry and Molecular and Cell Biology, University of Zaragoza, 50018 Zaragoza, Spain.ORCID 0000-0001-5702-4538
Sofía Díaz-MorenoDiamond Light Source-Harwell Science & Innovation Campus, OX11 0DE Didcot, United Kingdom.ORCID 0000-0001-7616-6515
Miguel A De la RosaInstitute for Chemical Research-cicCartuja, University of Seville-CSIC, 41092 Seville, Spain.ORCID 0000-0003-1187-5737
Irene Díaz-MorenoInstitute for Chemical Research-cicCartuja, University of Seville-CSIC, 41092 Seville, Spain.ORCID 0000-0002-5318-7644

Funding

Ministry of Science, Innovation and Universities FPU22/01094Ministry of Science, Innovation and Universities FPU24/00691Ministry of Science, Innovation and Universities PID2024-157414NB-I00Ministry of Science, Innovation and Universities PRE2019-091404Ramon Areces Foundation LEUCYTO-FRA2025-MARSpanish Council of Scientific Research JAEINT24_EX_0171Spanish Ministry of Education, Vocational Training and Sports 23CO1/008490Spanish State Research Agency
6 · The paper itself

Abstract

Nucleophosmin (NPM1) is a nucleolar protein commonly mutated in ~30% of newly diagnosed acute myeloid leukemia (AML) cases. These mutations occur in the terminal exon of the NPM1 gene, affecting the C-terminal DNA-binding domain of the protein and causing its delocalization to the cytoplasm-a hallmark of NPM1-mutated AML. NPM1 shuttling to the nucleoplasm is tightly regulated by posttranslational modifications, such as phosphorylation of Ser254, Ser260, and Tyr271 of the DNA-binding domain. However, the structural mechanisms underlying this process remain unclear. In this work, we show that Ser-to-Asp (S254D-S260D) and Tyr-to-pCMF (para-carboxymethyl phenylalanine) (Y271pCMF) phosphomimetic mutations induce significant structural and dynamical rearrangements, as well as drastic modifications in electrostatic surface potential. These changes compromise recognition of a G-quadruplex sequence from the c-MYC promoter by reducing DNA-binding affinity, reshape histone capturing dynamics, and fade charge segregation in the histone-binding domain. Combination of such substitutions in a triple phosphomimetic variant (S254D-S260D-Y271pCMF) further destabilizes the domain's structure and triggers protein aggregation. Altogether, these findings suggest that phosphorylation of Ser254, Ser260, and Tyr271 of the C-end DNA-binding domain weakens both DNA affinity and charge block-driven liquid-liquid phase separation, offering a molecular explanation for the delocalization of NPM1 outside of the nucleolus.

Indexed as

DNALeukemia, Myeloid, AcuteNuclear ProteinsG-QuadruplexesHumansMutationNucleophosminPhase SeparationPhosphorylationPromoter Regions, GeneticProtein BindingProtein DomainsProtein StabilityProto-Oncogene Proteins c-mycStatic ElectricityDNANPM1 protein, humanNuclear ProteinsNucleophosminProto-Oncogene Proteins c-myc

Identifiers

PMID41755632
PMCPMC12956350

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.